With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

Five years ago, I created Version 1.0 of the breakdown of the scholarship situation at WVU and the outgoing (and incoming) transfers. With the season now over for the Mountaineers, it's time to revamp ...